ALTA BIOPHARMA PARTNERS II LP's Net Worth

$180 Million

Estimate Recalculated Sep 16, 2024 07:01AM EST

Who is ALTA BIOPHARMA PARTNERS II LP?

ALTA BIOPHARMA PARTNERS II LP has an estimated net worth of $180 Million. This is based on reported shares across multiple companies, which include RENOVIS INC, CORCEPT THERAPEUTICS INC, RIGEL PHARMACEUTICALS INC, SCYNEXIS INC, and INTARCIA THERAPEUTICS, INC.

SEC CIK

ALTA BIOPHARMA PARTNERS II LP's CIK is 0001163156

Past Insider Trading and Trends

2014 was ALTA BIOPHARMA PARTNERS II LP's most active year for acquiring shares with 7 total transactions. ALTA BIOPHARMA PARTNERS II LP's most active month to acquire stocks was the month of April. 2014 was ALTA BIOPHARMA PARTNERS II LP's most active year for disposing of shares, totalling 6 transactions. ALTA BIOPHARMA PARTNERS II LP's most active month to dispose stocks was the month of April. 2014 saw ALTA BIOPHARMA PARTNERS II LP paying a total of $8,698,971.20 for 1,240,575 shares, this is the most they've acquired in one year. In 2014 ALTA BIOPHARMA PARTNERS II LP cashed out on 3,103,906 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RENOVIS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-42.00%
-500.00K
—
—
690.48K
Aug 8
Form 4
∞
2.17M
—
—
2.17M
Feb 10
Form 3
—
0
—
—
0
No matching records found

CORCEPT THERAPEUTICS INC (CORT) Snapshot price: $34.38

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
+6.58%
349.65K
$1.38
$482,518.38
5.66M
Oct 16
Form 4
+6.58%
349.65K
$1.38
$482,518.38
5.66M
Oct 16
Form 4
+2.01%
104.83K
$1.45
$151,997.70
5.31M
Nov 11
Form 4
+25.52%
1.06M
$2.77
$2,933,803.95
5.21M
Mar 25
Form 3
—
0
—
—
0
No matching records found

RIGEL PHARMACEUTICALS INC (RIGL) Snapshot price: $13.32

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-48.20%
-779.23K
$21.11
-$16,450,373.00
837.5K
Aug 20
Form 4
-0.85%
-3.10K
$21.50
-$66,650.00
360.48K
May 7
Form 4
-20.75%
-95.20K
$21.31
-$2,028,397.84
363.58K
May 3
Form 4
-1.80%
-8.40K
$21.25
-$178,500.00
458.78K
Apr 30
Form 4
-4.23%
-42.80K
$21.25
-$909,513.92
969.17K
Apr 28 - Apr 29
Form 4
-0.86%
-8.90K
$21.26
-$189,180.16
1.03M
Apr 26 - Apr 27
Form 4
-2.46%
-13.10K
$21.32
-$279,285.45
518.88K
Apr 23
Form 4
-0.82%
-8.80K
$21.26
-$187,122.13
1.07M
Apr 21 - Apr 22
Form 4
-10.03%
-60.30K
$21.00
-$1,266,342.21
540.78K
Apr 7
Form 4
-0.89%
-10.90K
$21.98
-$231,240.00
1.21M
Apr 5 - Apr 6
Form 4
-1.21%
-7.49K
$20.00
-$149,740.00
611.98K
Mar 24
Form 4/A
-10.73%
-74.46K
$20.00
-$1,489,280.00
619.47K
Feb 19
Form 4
-16.10%
-111.70K
$20.00
-$2,233,920.00
582.24K
Feb 19
No matching records found

SCYNEXIS INC (SCYX) Snapshot price: $1.28

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.29M
$9.06
—
1.29M
May 7
Form 3
—
0
—
—
0
No matching records found

INTARCIA THERAPEUTICS, INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found